You are right Flipper. I just want to say that when a big ex-chief from Merck says:”As I look forward now to the next wave of advances in immune therapies for cancer, I am excited about the potential of NW Bio's DCVax technologies to deliver new breakthroughs for patients.” the value of DCVAX -if DCVAX-L can prove its potential-is worth a lot more than just a couple of billion dollars.